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      From the DePartment of Pathology
  A survival study was made on 45’ renal cell carcinomas and 28 tumors of the renal pelvic and
ureter experienced at the Sapporo City General Hespital during the’ten years period， 1969－v 1978．
1’j Relative 5 year survival rate was 430／o in renal cell carcinoma and 300／o in renal pelvic and ureteral
 tumor．
2） Survival rate of renal cell carcinoma closely related with its stage． All the cases with advanced
 extension， tumor emboli in the renal vein or inferior vena cava or distant metastasis were dead
 within 4 years． AII but two of these cases showed striking acceleration of ESR and strongly positive
 CRP．
3） Relative 5 year survival rate of renal pelvic and ureteral tumor differed by grade． ln lew grade
 tumors， it was 1000／． ， while in high grade only 100／． which mostly belonged to the high stage group．
 Postoperative recurrence in the bladder was seen in 6 occasions in 3 patients． One case of early
 diagnosis was presented in which cytological study of the ureteral uripe through catheter’lead to
 diagnosis of carcinoma in situ of the renal pelvis．
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Table 1． Classification of tumor of the
     kindey and ureter
Type Totol








Table 2． Age and sex distribution
Kidney Pelvis and ureter
Age Male Femole Ma］e Femafie
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2   0
8   0
8   1




















求めた．Total 52 15 26 2
結 果
Table 3． Side and location
Right Left
  Kidney 22 23































Rena［ celI carcinoma （n：59）
Fig． 1．
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Renal pelvis and ureteral turnors
          （n＝22｝
Fig． 5．
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Relative survival rates of renal






















  1 2 3 4 5year
Relative survival rates related to grade



















































































関係があるとされ，Iow grade， Iow stageであれば予
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フトラフールズポ・ズポS
3つの吸収経路
1．フトラフールは主に肝臓で活性化され、活性物質である5・FU、FUR、
 FUMPの濃度が長時間持続します。この長時間持続性は代謝拮抗剤
 による癌化学療法において極めて重要なことです。
2．フトラフ画ルはmasked compoundのため、副作用が軽微で、長期連続
 投与が可能です。
3。初回治療にも非初回治療にも有効であり、癌化学療法における寛
 解導入のみならず、寛解強化療法、寛解維持療法として使用され
 特に病理組織学的に腺癌と診断された症例に有効です。
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